An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Monday, February 12, 2024
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
ChromaDex Corp. (NASDAQ:CDXC) will participate in Renmark Financial Communications Inc.’s live Virtual Non-Deal Roadshow Series on Monday, February 12, 2024, at 11:00 AM PST. The event will feature the latest investor presentation by CEO Rob Fried and CFO Brianna Gerber, followed by a live Q&A. Registration is limited, but the replay will be available on ChromaDex’s website. For more information, visit www.chromadex.com.
Positive
None.
Negative
None.
LOS ANGELES--(BUSINESS WIRE)--
ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, announced today that it will be participating in Renmark Financial Communications Inc.’s live Virtual Non-Deal Roadshow Series to discuss its latest investor presentation on Monday, February 12, 2024, at 11:00 AM PST. ChromaDex welcomes stakeholders, investors, and other individual followers to register and attend this live event.
The presentation will feature ChromaDex’s Chief Executive Officer, Rob Fried, and Chief Financial Officer, Brianna Gerber. Topics to be covered will include the latest investor presentation followed by a live Q&A. Investors interested in participating in this event will need to register using the link below. As a reminder, registration for the live event may be limited but access to the replay after the event will be on the Investor Relations section of ChromaDex’s website, investors.chromadex.com.
ChromaDex Corp. is a global bioscience company dedicated to healthy aging. The ChromaDex team, which includes world-renowned scientists, is pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. ChromaDex is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen®. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex’s patent portfolio. ChromaDex maintains a website at www.chromadex.com to which ChromaDex regularly posts copies of its press releases as well as additional and financial information about the Company.
About Renmark Financial Communications Inc.
Founded in 1999, Renmark is a privately held full-service investor relations firm, located in Atlanta, New York, Toronto, and Montreal. For the past 25 years, Renmark has provided services in investor relations, media relations, and web development representing small, medium, and large-cap public companies listed on all major North American exchanges. On a daily basis, our team of professionals enhances our clients’ visibility within the retail market space as corporate communicators. With the largest roadshow footprint in North America and a state-of-the-art media studio, we host a multitude of live-streaming Virtual Non-Deal Roadshows across North America and Europe.
When is ChromaDex participating in Renmark Financial Communications Inc.’s live Virtual Non-Deal Roadshow Series?
ChromaDex will participate in the live event on Monday, February 12, 2024, at 11:00 AM PST.
Who will be presenting at the event?
CEO Rob Fried and CFO Brianna Gerber will present the latest investor presentation.
Where can investors access the replay of the event?
The replay will be available on the Investor Relations section of ChromaDex’s website, investors.chromadex.com.
How can stakeholders and investors register for the event?
Interested stakeholders and investors can register for the event using the link provided: https://www.renmarkfinancial.com/live-registration/renmark-virtual-non-deal-roadshow-nasdaq-cdxc-2024-02-12-110000
What time should participants access the event link?
To ensure smooth connectivity, participants should access the event link using the latest version of Google Chrome.
chromadex corp. is an integrated, global nutraceutical company devoted to improving the way people age. chromadex scientists partner with leading universities and research institutions worldwide to uncover the full potential of nad and identify and develop novel, science-based ingredients including pteropure® pterostilbene; purenergy®, a caffeine-pteropure® co-crystal; anthorigin™, anthocyanins and niagen® nicotinamide riboside - sold directly to consumers as the supplement, tru niagen®. tru niagen® is helping the world age better®. for more, visit www.chromadex.com like us on facebook here: https://www.facebook.com/chromadex or follow us on twitter @chromadex chromadex® is publicly-traded company (nasdaq:cdxc).
